• Pliant Therapeutics Raises $62M to Develop Promising Therapies for Fibrotic Diseases
  • Celebrating Meaningful Milestones
  • Galapagos Announces New Phase 2 Trial Evaluating GLPG1205 in IPF Patients
  • The Dramatic Highs and Lows of a Patient with Pulmonary Fibrosis
  • PF, Other Respiratory Disorders May Be Linked to Type 2 Diabetes, Study Reports
  • NuMedii Collaborating with Teams of Experts to Develop Precision Therapies for IPF
  • Frustrating Things People Say to Patients with Pulmonary Fibrosis
  • Blood-Oxygen Levels of IPF Patient Sustained for Over 1 Year Using ECMO, Doctors in Japan Report
  • 6 Videos Packed with Tips for Reducing Supplemental Oxygen Hassle
  • Compound from Chinese Plant Seen to Protect Against Fibrosis in IPF Rat Model Study
  • Study Bias Likely Explains Link Between Antacid Therapy and Reduced Mortality in IPF, Research Suggests
  • Sometimes I Feel Like 2 Completely Different People